Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia. Issue 3 (23rd February 2022)

Record Type:: Journal Article
Title:: Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia. Issue 3 (23rd February 2022)
Main Title:: Plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia
Authors:: Parrondo, Ricardo D.
Paulus, Aneel
Alegria, Victoria
Liebowitz, David
Johnson, Chelsea
Clynes, Raphael
Roy, Vivek
Menke, David M.
Jiang, Liuyan
Chanan-Khan, Asher A.
Ailawadhi, Sikander
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 63:Issue 3(2022)
Journal:: Leukemia & lymphoma
Issue:: Volume 63:Issue 3(2022)
Issue Display:: Volume 63, Issue 3 (2022)
Year:: 2022
Volume:: 63
Issue:: 3
Issue Sort Value:: 2022-0063-0003-0000
Page Start:: 738
Page End:: 742
Publication Date:: 2022-02-23
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2021.2005045 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 21446.xml